NanoViricides Inc. (NNVC)

[crashco]

Grant money is also a real possibility. I don't disagree. I can imagine grants submitted by Eva Harris getting a boost if the Orphan Drug application is well received. Dr. Harris' lab tests using, systematically refined, DengueCide is an effort worth allocating some resources to. In a feedback informed "tuning"process 50% survival could be elevated to 90% or better. Pretty impressive results against an illness with no existing cure.

That said;
I hope FluCide remains NanoViricides' highest priority.